title: Ovarian reserve following uterine artery embolization in women of reproductive age: a preliminary report.
abstract: OBJECTIVE
  To evaluate the effect of uterine artery embolization (UAE) for leiomyomata on reproductive potential for women in their reproductive age group.
  
  
  METHODS
  This non-randomized, cross-sectional, observational study of ovarian reserve in women under 40 years of age who underwent UAE was conducted at a private practice located in Los Angeles, California. Twenty four women under 40 years of age who underwent UAE at least four months prior to study interventions were recruited. The study involved a one-time serum blood test on day three of the menstrual cycle and measured early follicular phrase follicle-stimulating hormone (FSH), anti-Müllerian hormone (AMH) and estradiol (E2) levels.
  
  
  RESULTS
  Descriptive analysis showed means of all outcome measures were within normal range of values [FSH = 6.67IU/L (SD = 2.3), AMH = 1.24 ng/ml (SD = 0.9), E2 = 58.8 pg/ml (SD = 18.0)].
  
  
  CONCLUSIONS
  Hormonal findings from this study were within normal ranges, suggesting that ovarian function is not adversely affected by UAE. Women with fibroids within reproductive age may consider UAE as a treatment option.
authors: UCLA, Obstetrics & Gynecology, Los Angeles, CA 90024-6999, USA. mclucas@ucla.edu
authors: Bruce
authors: B
authors: McLucas
authors: Hal
authors: H
authors: Danzer
authors: Carrie
authors: C
authors: Wambach
authors: Charlotte
authors: C
authors: Lee
mesh_terms: D000328:Adult; D054304:Anti-Mullerian Hormone / Q000097:blood; D003430:Cross-Sectional Studies; D004958:Estradiol / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D005498:Follicular Phase / Q000097:blood; D006801:Humans; D007889:Leiomyoma / Q000628:therapy*; D017063:Outcome Assessment, Health Care; D010050:Ovarian Function Tests; D010053:Ovary / Q000502:physiology*; D055357:Uterine Artery Embolization / Q000009:adverse effects / Q000379:methods*; D014594:Uterine Neoplasms / Q000628:therapy*
chemical_list: D004958:Estradiol; D054304:Anti-Mullerian Hormone; D005640:Follicle Stimulating Hormone